Regulatory Updates
Sep 19, 2026•1 min read
FDA Approves Multiple Supplemental Submissions for Phentermine Hydrochloride (ANDA 088596)
The FDA has approved a series of supplemental labeling and manufacturing submissions for the discontinued oral tablet Phentermine Hydrochloride (37.5 mg) under ANDA 088596.
Regulatory Updates
Sep 7, 2026•1 min read
Korean Pharmacists Association Welcomes Pharmacy Naming Law Amendment
The Korean Pharmacists Association praised the National Assembly’s passage of a Pharmacy Act amendment that restricts pharmacy names that could treat medicines as commodities or encourage over‑consumption.